Yasha S. Modi, MD, MHS, and Paula Pecen, MD, review two cases and discuss what OCT biomarkers to look for when determining when to refer a patient to a retina specialist for GA treatment.
GA Cases in the Primary Eye Care Clinic: Referring Earlier
Target Audience
This certified CME activity is designed for optometrists and comprehensive ophthalmologists who comanage or refer patients with AMD and GA.
Grantor Statement
This activity is supported by unrestricted educational grants from Astellas and Carl Zeiss Meditec.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Determine which patients with GA qualify for referral to a retinal specialist
- Recognize which imaging modalities and biomarkers are most useful for disease characterization
Accreditation and Credit Designation Statements
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Evolve Medical Education LLC is a COPE-accredited administrator.
Sponsored by
This activity, COPE Activity Number 130126, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hour of CE.
Course #: 96186-TD
Activity #: 130126COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
Faculty
Yasha S. Modi, MD, MHS (Chair)
Associate Professor of Ophthalmology
Department of Ophthalmology
Director of Tele-Retina
NYU Langone Health
New York, NYPaula Pecen, MD
Vitreoretinal Surgeon
Carolina Eye Associates
Greensboro, NCDisclosure of Relevant Financial Relationships
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.The following faculty/staff members have the following financial relationships with ineligible companies.
Yasha S. Modi, MD, MHS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie/Allergan, Alcon, Apellis Pharmaceuticals, Astellas, EyePoint Pharmaceuticals, Genentech, Notal Vision, Opthea, Regeneron, Topcon. Grant/Research Support: Genentech.
Paula Pecen, MD, has had no financial relationships or affiliations with ineligible companies.
The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Astellas, or Carl Zeiss Meditec.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- CME/CE Broadcast Replay
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
1.00 credit